Summit Therapeutics(SMMT)
$11.82-2.33 (-16.47%)
SMMT
Summit Therapeutics financials statements
$11.82
At close:-2.33 (-16.47%)
Want to see SMMT full AI Analyst Report?
Summit Therapeutics (SMMT) Income Statement
2,045 Followers
Summit Therapeutics Income Statement
Last quarter (Q3 2026), Summit Therapeutics's total revenue was £0.00. In Q3, Summit Therapeutics's net income was £-208.38M. See Summit Therapeutics’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| £ 0.00 | £ 0.00 | £ 0.00 | £ 705.00K | £ 1.81M | |
| £ 0.00 | £ 0.00 | £ 0.00 | £ 705.00K | £ 1.81M | |
| £ 1.09B | £ 226.00M | £ 609.65M | £ 72.79M | £ 88.00M | |
| Depreciation and Amortization | £ 146.00K | £ 111.00K | £ 252.00K | £ 1.53M | £ 3.32M |
| £ -1.08B | £ -210.88M | £ -88.48M | £ -62.09M | £ -85.00M | |
| £ -1.09B | £ -226.00M | £ -609.65M | £ -72.09M | £ -86.19M | |
| £ 14.84M | £ 4.68M | £ -5.28M | £ -6.69M | £ -2.42M | |
| £ -1.08B | £ -221.31M | £ -614.93M | £ -78.78M | £ -88.60M | |
| £ -1.08B | £ -221.31M | £ -614.93M | £ -78.78M | £ -88.60M | |
| Per Share Metrics | |||||
| Basic EPS | £ -1.44 | £ -0.31 | £ -0.99 | £ -0.41 | £ -0.96 |
| Diluted EPS | £ -1.44 | £ -0.31 | £ -0.99 | £ -0.41 | £ -0.96 |
| Weighted Average Shares Outstanding | 747.70M | 713.92M | 619.64M | 192.15M | 92.24M |
| Weighted Average Shares Outstanding (Diluted) | 747.70M | 718.54M | 619.65M | 193.34M | 92.24M |
Currency in GBP

